Indirect Treatment Comparison of the Efficacy and Safety of Sarilumab Monotherapy in Rheumatoid Arthritis Patients with Inadequate Response to Conventional Disease-Modifying Antirheumatic Drugs

被引：0
|
作者：
Ernest Choy
Nick Freemantle
Clare Proudfoot
Chieh-I Chen
Laurence Pollissard
Andreas Kuznik
Hubert van Hoogstraten
Erin Mangan
Paulo Carita
Thi-Minh-Thao Huynh
机构：
[1] Cardiff University,
[2] University College London,undefined
[3] Formerly of Sanofi,undefined
[4] Regeneron Pharmaceuticals,undefined
[5] Inc.,undefined
[6] Sanofi France,undefined
[7] Sanofi,undefined
来源：
Advances in Therapy | 2019年 / 36卷
关键词：
Biologic disease-modifying antirheumatic drugs; Network meta-analysis; Rheumatoid arthritis; Rheumatology; Sarilumab monotherapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：817 / 827
页数：10
相关论文
共 50 条
  • [1] Indirect Treatment Comparison of the Efficacy and Safety of Sarilumab Monotherapy in Rheumatoid Arthritis Patients with Inadequate Response to Conventional Disease-Modifying Antirheumatic Drugs
    Choy, Ernest
    Freemantle, Nick
    Proudfoot, Clare
    Chen, Chieh-I
    Pollissard, Laurence
    Kuznik, Andreas
    van Hoogstraten, Hubert
    Mangan, Erin
    Carita, Paulo
    Thi-Minh-Thao Huynh
    [J]. ADVANCES IN THERAPY, 2019, 36 (04) : 817 - 827
  • [2] Immunogenicity of Sarilumab Monotherapy in Patients with Rheumatoid Arthritis Who Were Inadequate Responders or Intolerant to Disease-Modifying Antirheumatic Drugs
    Alvin F. Wells
    Janie Parrino
    Erin K. Mangan
    Anne Paccaly
    Yong Lin
    Christine Xu
    Chunpeng Fan
    Neil M. H. Graham
    Hubert van Hoogstraten
    Albert Torri
    [J]. Rheumatology and Therapy, 2019, 6 : 339 - 352
  • [3] Immunogenicity of Sarilumab Monotherapy in Patients with Rheumatoid Arthritis Who Were Inadequate Responders or Intolerant to Disease-Modifying Antirheumatic Drugs
    Wells, Alvin F.
    Parrino, Janie
    Mangan, Erin K.
    Paccaly, Anne
    Lin, Yong
    Xu, Christine
    Fan, Chunpeng
    Graham, Neil M. H.
    van Hoogstraten, Hubert
    Torri, Albert
    [J]. RHEUMATOLOGY AND THERAPY, 2019, 6 (03) : 339 - 352
  • [4] Indirect Comparison of Tocilizumab and Other Biologic Agents in Patients with Rheumatoid Arthritis and Inadequate Response to Disease-Modifying Antirheumatic Drugs
    Bergman, Gert J. D.
    Hochberg, Marc C.
    Boers, Maarten
    Wintfeld, Neil
    Kielhorn, Adrian
    Jansen, Jeroen P.
    [J]. SEMINARS IN ARTHRITIS AND RHEUMATISM, 2010, 39 (06) : 425 - 441
  • [5] AN UPDATED MIXED TREATMENT COMPARISON OF BIOLOGIC TREATMENT IN RHEUMATOID ARTHRITIS PATIENTS WITH INADEQUATE RESPONSE TO DISEASE-MODIFYING ANTIRHEUMATIC DRUGS
    Rodriguez, M. F.
    Balmaceda, C.
    Espinoza, M. A.
    Rojas, R.
    Vargas, C.
    Dominguez, A.
    Duran, J.
    [J]. JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2018, 24 : S95 - S96
  • [6] Comparative Efficacy Of Novel Disease-Modifying Antirheumatic Drugs As Monotherapy and In Combination With Methotrexate In Rheumatoid Arthritis Patients With An Inadequate Response To Traditional Disease-Modifying Antirheumatic Drugs: A Network Meta-Analysis.
    Buckley, Felicity
    Finckh, Axel
    Huizinga, Thomas W. J.
    Dejonckheere, Fred
    Jansen, Jeroen P.
    [J]. ARTHRITIS AND RHEUMATISM, 2013, 65 : S201 - S202
  • [7] Comparison of Tocilizumab As Monotherapy or with Add-on Disease-Modifying Antirheumatic Drugs in Patients with Rheumatoid Arthritis and An Inadequate Response to Previous Treatments.
    Bykerk, Vivian
    Oestoer, Andrew
    Roman Ivorra, Jose Andres
    Wollenhaupt, Juergen
    Stancati, Andrea
    Bernasconi, Corrado
    Sibilia, Jean
    [J]. ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S866 - S867
  • [8] Sarilumab and Nonbiologic Disease-Modifying Antirheumatic Drugs in Patients With Active Rheumatoid Arthritis and Inadequate Response or Intolerance to Tumor Necrosis Factor Inhibitors
    Fleischmann, Roy
    van Adelsberg, Janet
    Lin, Yong
    Castelar-Pinheiro, Geraldo da Rocha
    Brzezicki, Jan
    Hrycaj, Pawel
    Graham, Neil M. H.
    van Hoogstraten, Hubert
    Bauer, Deborah
    Burmester, Gerd R.
    [J]. ARTHRITIS & RHEUMATOLOGY, 2017, 69 (02) : 277 - 290
  • [9] Effects of Conventional Synthetic Disease-Modifying Antirheumatic Drugs on Response to Periodontal Treatment in Patients with Rheumatoid Arthritis
    Jung, Gyu-Un
    Han, Ji-Young
    Hwang, Kyung-Gyun
    Park, Chang-Joo
    Stathopoulou, Panagiota G.
    Fiorellini, Joseph P.
    [J]. BIOMED RESEARCH INTERNATIONAL, 2018, 2018
  • [10] Economic Evaluation of Sarilumab in the Treatment of Adult Patients with Moderately-to-Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Conventional Synthetic Disease-Modifying Antirheumatic Drugs
    Muszbek, Noemi
    Proudfoot, Clare
    Fournier, Marie
    Chen, Chieh-, I
    Kuznik, Andreas
    Kiss, Zsofia
    Gal, Peter
    Michaud, Kaleb
    [J]. ADVANCES IN THERAPY, 2019, 36 (06) : 1337 - 1357
12345